plasminogen&#32

5 trials

Sponsors

Department of Nephrology, the First Affiliated Hospital of Army Military Medical University, Laboratory of shaping District People's Hospital of Chongqing, Huashan Hospital Affiliated to Fudan University, Zhongda Hospital Affiliated to Southeast University, Division of Gastroenterology, Union Hosptial, Tongji Medical College, Huazhong University of Science and Technology

Conditions

AKIUrosepsisacute kidney injurycontrast induced acute kidney injuryhepatic sinusoidal obstruction syndrome

Early Phase 1

Clinical application of a new biomarker suPAR in acute kidney injury

RecruitingChiCTR2000031004

Department of Nephrology, the First Affiliated Hospital of Army Military Medical Universityacute kidney injury

Start: 2020-03-25Updated: 2020-03-23

Study on the value of soluble urokinase type plasminogen activator receptor (suPAR) in early prediction of acute renal injury in critically ill patients

RecruitingChiCTR2000031695

Laboratory of shaping District People's Hospital of ChongqingAKI

Start: 2020-04-01Updated: 2020-04-13

The Early Warning Mechanism and Establishment of Standardized Diagnosis and Treatment System of Urosepsis Combined with Upper Urinary Tract Calculi

Active, not recruitingChiCTR2000037855

Huashan Hospital Affiliated to Fudan UniversityUrosepsis

Start: 2020-10-01Updated: 2020-11-09

The predictive value of soluble urokinase-type plasminogen activator receptor in contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention

RecruitingChiCTR2100050487

Zhongda Hospital Affiliated to Southeast Universitycontrast induced acute kidney injury

Start: 2021-09-01Updated: 2022-05-02

Unknown Phase

Diagnostic value and prognostic evaluation of imaging modality (CT, MRI) and serological biomarkers in hepatic sinusoidal obstruction syndrome induced by pyrrolidine alkaloid

RecruitingChiCTR-DRD-17010709

Division of Gastroenterology, Union Hosptial, Tongji Medical College, Huazhong University of Science and Technologyhepatic sinusoidal obstruction syndrome

Start: 2017-02-01Updated: 2017-04-18

Related Papers

Prognostic factors for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: a multicenter study in China

Annals of Translational Medicine2021-01-0117 citations

Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study.

2020-02-0417 citations